SGS Nutrasource’s Radioactivity Tested & Certified Program Welcomes First Partner, GNC China
September 30, 2024
Within its first month, program sees strong interest and welcomes significant brand as first client.
Microbio Co., Ltd. Achieves Self-Affirmed GRAS for Symbiota®
July 22, 2024
Symbiota® is a soybean fermentate using a combination of 19 bacterial strains and the yeast Saccharomyces cerevisiae or mixtures of these strains.
SGS Nutrasource Introduces International Algal Oil Standards (IAOS™) Product Certification
April 30, 2024
Program Empowers Algal Oil Omega-3 Manufacturers and Brands to Showcase Their Commitment to Quality and Transparency
Tagatose Becomes First Sweetener and Ingredient to Earn NutraStrong™ Prebiotic Verified Certification
March 14, 2024
Tagatose Becomes First Sweetener and Ingredient to Earn NutraStrong Prebiotic Verified Certification
OLIPOP Joins NutraStrong™ Prebiotic Verified Product Certification
October 23, 2023
New program developed in collaboration between the Global Prebiotics Association (GPA) and SGS Nutrasource.
GRAS Associates Receives FDA “No Questions” GRAS Notice Letter for OraTicx’s Probiotic Ingredient
June 06, 2023
Successful notification for Weissella cibaria CMU as an ingredient in various food products, paving the way for global market entry of oraCMU® oral probiotic.
NASC Announces Successful Tolerability Study of Cannabidiol Products in Healthy Dogs
May 16, 2023
Collaborative Study with Nutrasource Evaluates Tolerability of Supplementation and Determine Safe Dosage
SGS Acquires a Majority Stake in Nutrasource
May 11, 2023
The initial investment is 60% of shares of Nutrasource, with the right to acquire the remaining 40% of shares in 2026.
Korean Health Supplements Association (KHSA) Approves Use of IFOS™ Logo on Korean Manufactured Omega-3 Product Packaging
April 11, 2023
Approval is a First for Korean Manufactured Supplement Products
Apex Trials Joins hyperCORE International's Clinical Trial Network
January 30, 2023
The partnership will bring hyperCORE new and expanded capabilities in health product development, including dietary supplements, medical foods and devices, biologics, and other pharmaceuticals.